매상 변화 날짜
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 450.82M 375.59M 2026-09
AstraZeneca USD 16.21B 830M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Halozyme Therapeutics USD 492.97M 11.97M 2026-09
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 524.42M 98.93M 2026-09
J&J USD 25.4B 89M 2026-09
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Ligand Pharmaceuticals USD 78.75M 4.95M 2026-09
Merck USD 18.1B 1.5B 2026-09
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 1.31M 98.69M 2026-09
Novartis USD 15.03B 1.92B 2026-09
Pfizer USD 16.6B 1.57B 2026-09
PTC Therapeutics USD 357.8M 3.2M 2026-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 14.44B 2.49B 2026-09
Takeda JPY 1.19T 32.9B 2026-09
Teva Pharmaceutical Industries USD 4.37B 8.3B 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Veracyte USD 151.75M 1.43M 2026-09